Genome-scale CRISPR screening identifies cell cycle and protein ubiquitination processes as druggable targets for erlotinib-resistant lung cancer
Ontology highlight
ABSTRACT: Genome-scale CRISPR screening identifies cell cycle and protein ubiquitination processes as druggable targets for erlotinib-resistant lung cancer
PROVIDER: PRJNA597891 | ENA |
REPOSITORIES: ENA
ACCESS DATA